Peptide Synthesis Market: Major Growth Driving Factors & Revenue Growth Projections

Posted by MV Mukund on April 1st, 2024

Overview of This Study:

In order to estimate the current size of the peptide synthesis market, this study covered four primary operations. A thorough investigation was conducted using secondary research methods to gather data about the market, its parent market, and its peer markets. The following stage involved conducting primary research to confirm these conclusions, hypotheses, and sizing with industry experts throughout the value chain. To estimate the total market size, various methodologies, including top-down techniques, were utilized. The market size of the various segments and subsegments was then estimated using data triangulation techniques and market breakdown.

Market Size Estimation:

To determine and validate the overall size of the peptide synthesis market, a top-down methodology was employed. Additionally, this approach was widely utilized to calculate the market's subsegment sizes. The following is a list of the research methods utilized to determine the market size:

# The key players in the industry and market have been identified through extensive secondary research.
# The revenues generated from the peptide synthesis business of leading players have been determined through primary interviews and secondary research.
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158927365

Major Growth Driving Factors:

The expanding medicinal uses, technological developments in peptide synthesis, and rising peptide demand are driving growth in this market. In addition, increased spending on R&D, a thriving industry, and the use of peptides in pharmaceutical products are some of the key factors expected to propel market expansion. Nonetheless, during the course of the forecast period, the absence of a single set of laws pertaining to therapeutic peptides and the high cost of instruments are anticipated to impede the market's expansion.

Revenue Growth Projections:

The global peptide synthesis market in terms of revenue was estimated to be worth 1 million in 2023 and is poised to reach 9 million by 2028, growing at a CAGR of 7.4% from 2023 to 2028.

Data Triangulation:

Following the completion of the market size assessment process, the entire market was divided into a number of segments and sub-segments. Data triangulation and market breakdown processes were used where appropriate to finish the entire market engineering process and yield precise statistics for all segments and subsegments. Through an analysis of numerous variables and patterns from the supply and demand sides, the data was triangulated.

Driver: Peptides are being used in pharmaceutical products more often.

Peptides are very specific and very potent pharmaceutical ingredients. They have a wide range of therapeutic applications because of the diversity of their biological roles. Because of their wide molecular space, high biological activity, high specificity, simplicity of synthesis, accessibility, and low toxicity, peptides are making their way into the drug development process as possible active medicinal ingredients. Because of their therapeutic potential, high specificity and low toxicity, versatility and diversity, improvements in peptide synthesis technologies, potential use as drug candidates, emergence of personalized medicine, and rising interest in and funding for peptide-based therapeutics, peptides are becoming more and more common in the pharmaceutical industry. All of these elements work together to make peptides a more important class of molecules in the creation of innovative and focused pharmacological treatments.

Restraint: Exorbitant instrument costs

High-throughput, quick systems are used in the synthesis of proteins. Advanced features and functions in chromatography equipment, such as peptide synthesizers, typically come at a premium price. Users of peptide synthesizers have total control over the synthesis process and can choose from fully automated, manual, or semi-automated models. Peptide synthesizers range in price from USD 300,000 to USD 250,000, depending on the automation and cutting-edge technologies they support. It is challenging for developing nations to experiment with peptide synthesis due to the exorbitant costs of the necessary tools. These instruments are expensive because of advances in technology. Furthermore, it is expensive to maintain these devices because it calls for consumables, chemicals, spare parts, and regular servicing.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=158927365

Opportunity: Creation of individualized medications

The peptide synthesis sector has significant growth prospects due to the emergence of personalized medicine. Peptides provide the necessary targeting, customisation, and specificity to enable individualized treatment plans. It is anticipated that the need for peptide synthesis technology, services, and products will increase dramatically as personalized medicine continues to develop and gain popularity.

Key Players:

The prominent players operating in the peptide synthesis market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Kaneka Corporation (Japan), GenScript Biotech Corporation (China), and Bachem Holding AG (Switzerland).

Different Growth Strategies Adopted by Them:

Most companies in the market focus on organic and inorganic growth strategies, such as service launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their service offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Like it? Share it!


MV Mukund

About the Author

MV Mukund
Joined: March 18th, 2020
Articles Posted: 77

More by this author